← Open Payments lookup

TRACY BURNS: Open Payments

NPI 1235619206 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,440 in 93 payments from 11 companies in 2025. Trend: 2023 $2,120 · 2024 $1,653 · 2025 $1,440

Food & beverage: $1,440
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$325
ABBVIE INC.25$253
Collegium Pharmaceutical, Inc.21$241
Neurocrine BioSciences, Inc.12$168
Supernus Pharmaceuticals, Inc.5$90
Alkermes, Inc.4$87
Axsome Therapeutics, Inc.3$77
Otsuka America Pharmaceutical, Inc.3$74
Takeda Pharmaceuticals U.S.A., Inc.3$68
Vanda Pharmaceuticals Inc.2$42

Products named: CAPLYTA, VRAYLAR, Jornay PM, INGREZZA, Qelbree, ARISTADA, Auvelity, TRINTELLIX.

Industry payments across MS — which companies pay providers there.